Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|January 4, 2015
Studying RNA-binding protein interactions with target mRNAs in eukaryotic cells: native ribonucleoprotein immunoprecipitation (RIP) assaysJoseph A Cozzitorto, Masaya Jimbo, Saswati Chand, et al.
Journal of the American College of Surgeons|February 10, 2018
A Sub-Type of Familial Pancreatic Cancer: Evidence and Implications of Loss-of-Function Polymorphisms in Indoleamine-2,3-Dioxygenase-2Avinoam Nevler, Alexander J Muller, Joseph A Cozzitorto, et al.
Cancer Research|June 3, 2009
The role of HuR in gemcitabine efficacy in pancreatic cancer: HuR Up-regulates the expression of the gemcitabine metabolizing enzyme deoxycytidine kinaseChristina L Costantino, Agnieszka K Witkiewicz, Yuki Kuwano, et al.
Cancer Biology & Therapy|August 28, 2010
CanScript, an 18-Base pair DNA sequence, boosts tumor cell-specific promoter activity: implications for targeted gene therapyYu-Hung Huang, Joseph A Cozzitorto, Nathan G Richards, et al.
Annals of Surgery|August 27, 2010
HuR status is a powerful marker for prognosis and response to gemcitabine-based chemotherapy for resected pancreatic ductal adenocarcinoma patientsNathan G Richards, David W Rittenhouse, Boris Freydin, et al.
RNA Biology|June 29, 2013
HuR is a post-transcriptional regulator of core metabolic enzymes in pancreatic cancerRichard A Burkhart, Danielle M Pineda, Saswati N Chand, et al.
Plos One|December 15, 2010
pp32 (ANP32A) expression inhibits pancreatic cancer cell growth and induces gemcitabine resistance by disrupting HuR binding to mRNAsTimothy K Williams, Christina L Costantino, Nikolai A Bildzukewicz, et al.
Cancer Research|February 19, 2014
HuR posttranscriptionally regulates WEE1: implications for the DNA damage response in pancreatic cancer cellsShruti Lal, Richard A Burkhart, Neil Beeharry, et al.
Molecular Cancer Research : MCR|October 23, 2014
MUC1 Promoter-Driven DTA as a Targeted Therapeutic Strategy against Pancreatic CancerRenee M Tholey, Shruti Lal, Masaya Jimbo, et al.
Cancer Biology & Therapy|July 13, 2012
HuR's post-transcriptional regulation of Death Receptor 5 in pancreatic cancer cellsDanielle M Pineda, David W Rittenhouse, Christopher C Valley, et al.
Pageof 2